查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2024668

心血管器材市場報告：按器材類型、應用、最終用戶和地區分類，2026-2034年

Cardiovascular Devices Market Report by Device Type, Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, and Others), End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年全球心血管器材市場規模達658億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到1,064億美元，2026年至2034年的複合年成長率為5.32%。介入性心臟病學手術的引入，以及有利的報銷政策，正在推動市場成長。

心血管器材市場趨勢：

對微創手術的需求

推動市場發展的因素之一是人們的偏好從傳統的開胸手術轉向創傷較小的調查方法，這些方法能夠縮短恢復時間、降低手術風險並改善患者預後。例如，2024年4月，由戈爾韋大學研究團隊主導的「快速通道冠狀動脈繞道手術」（FAST TRACK CABG）研究首次測試了一種規劃、引導和實施心臟繞道手術的新方法。該研究表明，採用人工智慧驅動的血流掃描功能的非侵入性心臟CT是可行且安全的。此外，機器人技術和即時成像技術的普及使得無需大切口即可精準植入瓣膜、支架和其他醫療設備，這也促進了心血管器械市場的收入成長。例如，2024年2月，飛利浦發布了「LumiGuide」系統，該系統採用光纖RealShape（FORS）技術，可實現無輻射的微創手術。此外，微創手術透過微小切口，利用專用心血管器械和先進的影像技術進行，從而實現精準標靶治療。常見的例子包括經導管二尖瓣瓣膜修復（TMVR）、經導管主動脈瓣置換術（TAVR）和內視鏡靜脈取血管術。因此，這些技術正在全球廣泛應用。例如，2022年12月，全球領先的醫療保健公司之一雅培宣布推出Navitor，這是一種新型經導管主動脈瓣置換術（TAVI）系統，適用於患有嚴重主動脈瓣狹窄且手術風險高或極高的印度患者。隨著技術的進步，這些手術變得越來越有效、越來越安全，因此在多種心血管疾病的治療中得到越來越廣泛的應用。例如，2024 年 5 月，在美國心血管血管造影術和介入學會 (SCAI) 年會上公佈的新的一年追蹤數據顯示，Anteris Technologies 開發的一種新型仿生經導管主動脈瓣置換術(TAVR) 系統可以為心臟科醫生提供治療嚴重主動脈瓣狹窄 (AS) 的新選擇。

引進改良型設備

心血管器械在慢性心臟疾病和中風的治療、診斷和管理中發揮著至關重要的作用。因此，領導企業不斷向市場推出新型器械，使醫療專業人員能夠準確評估心血管疾病的嚴重程度、監測患者的心臟健康狀況並提高治療方法效果。此外，需要介入治療心血管疾病的患者數量不斷增加，推動了對智慧支架、植入式心臟節律器和去心房顫動的需求。這反過來又對心血管器械市場的前景產生了積極影響。例如，2023年12月，泰爾茂印度公司宣布推出用於治療冠狀動脈疾病的藥物釋放型支架Ultimaster Nagomi。此外，加大研發投入以推出包括心臟節律器在內的改良型心血管器械也是推動市場成長的關鍵因素。例如，2023年5月，全球領先的心臟節律管理設備開發商之一－微創醫療器材公司（MicroPort）的Alizea和Celea系列植入式心臟節律器獲得美國食品藥物管理局（FDA）核准。此外，這些產品也採用了微創醫療器材公司自主研發的「AutoMRI模式」演算法，旨在提升病患在進行磁振造影檢查時的安全性。同樣，2023年7月，雅培公司宣布其無導線心臟節律器系統「Aveir DR」獲得FDA核准。此外，機器學習和人工智慧技術正被用於分析大量的心血管數據，從而實現個人化治療方案的發展、患者預後的預測以及診斷準確性的提升。例如，2024年1月，由美國梅奧診所心臟病專家Demirade Adedinsewo博士主導的一項研究表明，人工智慧驅動的數位聽診器可以提高周產期心肌病（一種可能危及生命的疾病，會導致孕婦心肌功能減弱）的診斷準確性。

策略聯盟

主要企業、醫療設備製造商、研究機構和醫療保健組織正積極開展合作、併購，以推出包括精準影像工具在內的循環系統醫療設備。這代表了循環系統醫療設備市場近期的一大機會。例如，2023年9月，領先的心臟資料管理平台之一PaceMate宣布與MedAxiom合作，在單一的雲端原生環境中建立心臟資料和電子健康記錄（EHR）資料的工作流程解決方案。隨後，2023年10月，GE醫療與波士頓科學公司合作開發先進的心臟影像影像系統。此外，這些合作關係有助於企業應對複雜的監管環境，並透過利用合作夥伴的本地專業知識和成熟的分銷網路進入國際市場。例如，2023年6月，飛利浦與百多力合作，擴展了飛利浦SymphonySuite客戶可使用的心血管器材產品線。 2023 年 5 月，PaceMate 也透過與 AliveCor 合作，將業務擴展到植入式心臟裝置領域。 AliveCor 是 FDA已通過核准的個人心電圖技術和遠端病患管理解決方案的全球領導者。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球心血管器材市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依設備類型分類

  • 診斷和監測設備
    • 主要部分
      • 心電圖（ECG）
      • 遠端心臟監測
      • 其他
  • 治療及外科醫療設備
    • 主要部分
      • 心臟節律管理（CRM）設備
      • 導管
      • 支架
      • 心臟瓣膜
      • 其他

第7章 市場區隔：依應用領域分類

  • 冠狀動脈疾病（CAD）
  • 心律不整
  • 心臟衰竭
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 專科診所
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • B. Braun SE
    • Biotronik
    • Boston Scientific Corporation
    • Canon Medical Systems Corporation
    • Cordis（Cardinal Health Inc.）
    • Edwards Lifesciences Corporation
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • LivaNova PLC
    • Medtronic Plc
    • Terumo Cardiovascular Systems Corporation
    • WL Gore & Associates, Inc.
Product Code: SR112026A5240

The global cardiovascular devices market size reached USD 65.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 106.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5.32% during 2026-2034. The introduction of interventional cardiology procedures, coupled with favorable reimbursement policies, are stimulating the market growth.

CARDIOVASCULAR DEVICES MARKET ANALYSIS:

  • Major Market Drivers: The increasing number of cardiovascular conditions, such as heart failure, coronary artery disease, arrhythmias, etc., is propelling the market. Moreover, the rising consumer inclination towards minimally invasive alternatives to traditional open-heart surgeries for faster recovery, reduced hospital stays, improved patient comfort, etc., is also acting as another significant growth-inducing factor.
  • Key Market Trends: The growing advancements in 3D printing and artificial intelligence (AI) technologies that are leading to the launch of advanced cardiovascular devices to offer enhanced precision and safety are among the emerging trends stimulating the overall market.
  • Geographical Trends: The well-developed healthcare infrastructures are bolstering the market in North America. Apart from this, the presence of major medical device manufacturers and the elevating investments in R&D activities are further positively influencing the regional market.
  • Competitive Landscape: According to the cardiovascular devices market overview, some of the prominent companies across the global market include Abbott Laboratories, B. Braun SE, Biotronik, Boston Scientific Corporation, Canon Medical Systems Corporation, Cordis (Cardinal Health Inc.), Edwards Lifesciences Corporation, Lepu Medical Technology (Beijing) Co., Ltd., LivaNova PLC, Medtronic Plc, Terumo Cardiovascular Systems Corporation, and W. L. Gore & Associates, Inc., among many others.
  • Challenges and Opportunities: The launch of cardiovascular devices involves complex engineering and integration of advanced materials, which can hamper the market growth. However, key players are ensuring the long-term reliability and safety of these devices, particularly those that are implantable. This, in turn, will continue to augment the global market in the coming years.

CARDIOVASCULAR DEVICES MARKET TRENDS:

Demand for Minimally Invasive Procedures

The shifting preferences of individuals from traditional open-heart surgeries toward less invasive methodologies that minimize recovery times, reduce surgical risks, improve patient outcomes, etc., are stimulating the market. For example, in April 2024, the FAST TRACK CABG study, overseen by a team of researchers at the University of Galway, tested a new approach to the planning, guidance, and conducting of heart bypass surgery on patients for the first time. It demonstrated that non-invasive cardiac CT with AI-powered blood flow scanning is feasible and safe. Besides this, the widespread adoption of robotics and real-time imaging techniques facilitates the accurate placement of valves, stents, and other devices without the need for large incisions, which is also elevating the cardiovascular devices market revenue. For instance, in February 2024, Philips introduced LumiGuide, which is powered by Fiber Optic RealShape (FORS) technology, for radiation-free, minimally invasive surgeries. Apart from this, minimally invasive procedures are performed via small incisions using specialized cardiovascular instruments and advanced imaging techniques, which allow for targeted and precise treatments. Some of the common examples include transcatheter mitral valve repair (TMVR), transcatheter aortic valve replacement (TAVR), endoscopic vein harvesting, etc. Consequently, they are gaining traction across the globe. For example, in December 2022, Abbott, one of the leading global healthcare companies, announced the launch of its novel transcatheter aortic valve implantation (TAVI) system, Navitor, for individuals in India with severe aortic stenosis who are at high or extreme surgical risk. As technology advances, these procedures are becoming more effective and safer, thereby leading to their increasing adoption in treating numerous cardiovascular conditions. For instance, in May 2024, according to new one-year data presented at the annual meeting of the Society for Cardiovascular Angiography and Interventions (SCAI), a new biomimetic transcatheter aortic valve replacement (TAVR) system developed by Anteris Technologies can offer cardiologists with a new way to treat severe aortic stenosis (AS).

Introduction of Enhanced Variants

Cardiovascular devices play a crucial role in the treatment, diagnosis, and management of chronic heart conditions and stroke. Consequently, key players are launching novel devices that enable healthcare professionals to accurately assess the severity of cardiovascular diseases, monitor the heart health of patients, improve effective therapies, etc. Moreover, the increasing number of patients requiring intervention to address their cardiovascular conditions is escalating the popularity of smart stents, implantable pacemakers, defibrillators, etc. This, in turn, is positively influencing the cardiovascular devices market outlook. For example, in December 2023, Terumo India announced the launch of Ultimaster Nagomi, a drug-eluting stent intended for use in the treatment of coronary artery disease. Besides this, the growing investments in R&D activities to introduce improved cardiovascular devices, including pacemakers, are acting as significant growth-inducing factors. For instance, in May 2023, MicroPort, one of the global developers in the field of cardiac rhythm management, received FDA approval for its wide range of implantable pacemakers, Alizea and Celea. Additionally, they feature AutoMRI mode, an algorithm invented by MicroPort, that increases the safety of patients who are undergoing an MRI examination. Similarly, in July 2023, Abbott announced the FDA approval of its leadless pacemaker system, Aveir DR. Furthermore, machine learning and AI are employed for analyzing vast amounts of cardiovascular data to personalize treatment plans, predict patient outcomes, improve diagnostic accuracies, etc. For example, in January 2024, research led by Dr. Demilade Adedinsewo, one of the cardiologists at the Mayo Clinic in the U.S., suggested that the AI-enabled digital stethoscope could improve the diagnosis of peripartum cardiomyopathy, a potentially life-threatening condition that weakens the heart muscle of women during pregnancy.

Strategic Partnerships

Prominent companies, medical device manufacturers, research institutions, and healthcare organizations are collaborating and entering into mergers and acquisitions activities to introduce cardiovascular devices, including precise imaging tools. This represents one of the cardiovascular devices market recent opportunities. For instance, in September 2023, PaceMate, one of the leading cardiac data management platforms, announced the partnership with MedAxiom to create workflow solutions for cardiac and EHR data in a single, cloud-native environment. In line with this, in October 2023, GE HealthCare collaborated with Boston Scientific to develop enhanced cardiac imaging systems. Additionally, these partnerships aid companies in navigating complex regulatory landscapes and gaining access to international markets by leveraging the local expertise and established distribution networks of their partners. For example, in June 2023, Philips entered into a partnership with Biotronik to expand the range of cardiovascular devices available for Philips SymphonySuite customers. Besides this, in May 2023, PaceMate collaborated with AliveCor, one of the global leaders in FDA-cleared personal electrocardiogram technology and remote patient management solutions, to encompass implantable cardiac devices.

CARDIOVASCULAR DEVICES MARKET SEGMENTATION:

Breakup by Device Type:

  • Diagnostic and Monitoring Devices
    • Electrocardiogram (ECG)
    • Remote Cardiac Monitoring
    • Others
  • Therapeutic and Surgical Devices
    • Cardiac Rhythm Management (CRM) Devices
    • Catheter
    • Stents
    • Heart Valves
    • Others

Therapeutic and surgical devices is the most popular device type

The increasing number of surgical procedures and therapeutic interventions aimed at treating cardiovascular diseases is propelling the segment's growth. Moreover, therapeutic and surgical devices include implantable cardioverter defibrillators (ICDs), stents, pacemakers, catheters, heart valves, ventricular assist devices (VADs), etc. They aid in regulating heart rhythm, restoring blood flow, providing mechanical circulatory support, etc. Consequently, they are gaining extensive traction as less invasive alternatives to traditional open-heart surgeries, which is elevating the cardiovascular devices market demand. For example, in December 2023, Medtronic plc, one of the global leaders in healthcare technologies, announced the FDA approval of the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF). In line with this, in June 2023, Magenta Medical launched a feasibility study for the world's smallest heart pump that reduces vascular access complications during heart surgery.

Breakup by Application:

  • Coronary Artery Disease (CAD)
  • Cardiac Arrhythmia
  • Heart Failure

Coronary artery disease (CAD) dominates the cardiovascular devices market share

CAD devices used for treatment, diagnosis, and management of coronary artery disease condition are gaining traction across countries. Moreover, the widespread adoption of diagnostic devices, such as intravascular ultrasound (IVUS) devices, angiography systems, and computed tomography angiography (CTA) machines, as they help in assessing the severity of coronary artery blockages, is propelling the market. For example, in August 2022, Medtronic announced the launch of its novel drug-eluting coronary stent, the Onyx Frontier drug-eluting stent (DES), following CE Mark approval. Besides this, in January 2024, Cleerly, one of the companies working to create a new standard of care for the diagnosis of heart disease, introduced Cleerly ISCHEMIA, which recently received U.S. Food and Drug Administration (FDA) 510(k) medical device clearance. Cleerly ISCHEMIA analysis software is an automated machine learning-based decision support tool specifically designed for patients undergoing coronary computed tomography angiography (CCTA).

Breakup by End User:

  • Hospitals
  • Specialty Clinics

Hospitals account for the majority of the overall market share

Hospitals are the primary end users of cardiovascular devices. They provide a wide range of cardiac services, such as treatment, diagnosis, and surgical procedures for cardiovascular diseases. Hospitals have cardiac catheterization labs and specialized cardiology departments equipped with advanced imaging systems and surgical suites, which is increasing the cardiovascular devices market's recent price. For instance, in January 2024, Sylvia Jones, the health minister of Ontario, announced the development of a new cardiac lab at St. Mary's General Hospital in Kitchener, Canada, to help cardiac patients. They require a comprehensive range of devices, such as implantable devices, diagnostic equipment, surgical instruments, monitoring systems, etc., which is driving the growth in this segmentation.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest market for cardiovascular devices.

The increasing prevalence of cardiovascular conditions, including stroke and peripheral artery disease, is propelling the regional market. For instance, as per the report published by the Heart and Stroke Foundation of Canada in February 2022, there were 750,000 patients diagnosed with heart failure. Moreover, favorable reimbursement policies and fast regulatory approvals are acting as significant growth-inducing factors. For example, in September 2023, CorVista Health announced the FDA approval of its non-invasive medical device system that is used for detecting the presence of cardiac disease. In line with this, in January 2024, Occlutech, a Swedish medical device company focused on structural heart disease, received the U.S. FDA approval for its ASD Occluder for the treatment of atrial septal defects (ASDs). Apart from this, as per the cardiovascular devices market statistics, the introduction of wireless ECG has allowed for real-time patient monitoring and diagnosis. This, in turn, will continue to stimulate the regional market in the coming years. For example, in February 2021, VivaLNK developed a wearable ECG monitoring solution designed to wirelessly capture ECG and heart rate during a six-minute walk test (6MWT).

COMPETITIVE LANDSCAPE:

The key players are investing significantly in R&D to develop innovative cardiovascular devices. They focus on improving device performance, durability, and patient outcomes. R&D efforts aim to introduce advanced technologies, such as minimally invasive procedures, remote monitoring systems, and personalized medicine approaches. Additionally, cardiovascular devices market companies are continuously launching new cardiovascular devices to expand their product portfolios. These launches often involve next-generation devices with improved features and enhanced capabilities. They are prioritizing addressing unmet clinical needs, such as novel therapies for specific cardiovascular conditions or devices that offer improved precision and ease of use. Besides this, collaborations and partnerships between key players, healthcare providers, and research institutions are common in the cardiovascular devices market. These collaborations foster innovation, facilitate knowledge exchange, and leverage collective expertise and resources to develop and commercialize new technologies and solutions.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • B. Braun SE
  • Biotronik
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Cordis (Cardinal Health Inc.)
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LivaNova PLC
  • Medtronic Plc
  • Terumo Cardiovascular Systems Corporation
  • W. L. Gore & Associates, Inc.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiovascular Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device Type

  • 6.1 Diagnostic and Monitoring Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Electrocardiogram (ECG)
      • 6.1.2.2 Remote Cardiac Monitoring
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutic and Surgical Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Cardiac Rhythm Management (CRM) Devices
      • 6.2.2.2 Catheter
      • 6.2.2.3 Stents
      • 6.2.2.4 Heart Valves
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Coronary Artery Disease (CAD)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiac Arrhythmia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Heart Failure
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun SE
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Biotronik
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Boston Scientific Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Canon Medical Systems Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Cordis (Cardinal Health Inc.)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Edwards Lifesciences Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Lepu Medical Technology (Beijing) Co., Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 LivaNova PLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Medtronic Plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Terumo Cardiovascular Systems Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 W. L. Gore & Associates, Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Cardiovascular Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiovascular Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Cardiovascular Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Cardiovascular Devices Market: Breakup by Device Type (in %), 2025
  • Figure 5: Global: Cardiovascular Devices Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Cardiovascular Devices Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Cardiovascular Devices Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Cardiovascular Devices (Diagnostic and Monitoring Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Cardiovascular Devices (Diagnostic and Monitoring Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Cardiovascular Devices (Therapeutic and Surgical Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Cardiovascular Devices (Therapeutic and Surgical Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Cardiovascular Devices (Coronary Artery Disease-CAD) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Cardiovascular Devices (Coronary Artery Disease-CAD) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Cardiovascular Devices (Cardiac Arrhythmia) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Cardiovascular Devices (Cardiac Arrhythmia) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Cardiovascular Devices (Heart Failure) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Cardiovascular Devices (Heart Failure) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Cardiovascular Devices (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Cardiovascular Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Cardiovascular Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Cardiovascular Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Cardiovascular Devices (Specialty Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Cardiovascular Devices (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Cardiovascular Devices (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Cardiovascular Devices (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: North America: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: North America: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: United States: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: United States: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Canada: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Canada: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Asia-Pacific: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Asia-Pacific: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: China: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: China: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Japan: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Japan: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: India: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: India: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: South Korea: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: South Korea: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Australia: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Australia: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Indonesia: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Indonesia: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Others: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Others: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Europe: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Europe: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Germany: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Germany: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: France: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: France: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: United Kingdom: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: United Kingdom: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Italy: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Italy: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Spain: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Spain: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Russia: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Russia: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Others: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Others: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Latin America: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Latin America: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Brazil: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Brazil: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Mexico: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Mexico: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Middle East and Africa: Cardiovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Middle East and Africa: Cardiovascular Devices Market: Breakup by Country (in %), 2025
  • Figure 74: Middle East and Africa: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Global: Cardiovascular Devices Industry: SWOT Analysis
  • Figure 76: Global: Cardiovascular Devices Industry: Value Chain Analysis
  • Figure 77: Global: Cardiovascular Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiovascular Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Cardiovascular Devices Market Forecast: Breakup by Device Type (in Million USD), 2026-2034
  • Table 3: Global: Cardiovascular Devices Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Cardiovascular Devices Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Cardiovascular Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Cardiovascular Devices Market: Competitive Structure
  • Table 7: Global: Cardiovascular Devices Market: Key Players